| Application no. and date | 16702585.7 (espacenet) (Federated) (European Patent Register), 20160105 | | Patent/reg. no. and date | DK/EP 3244917, 20230419 | | Publication date | 20171122 | | Priority no. and date | US 201562103630 P, 20150115 | | EP pub. no. and date |
EP 3244917 20171122 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V457440DK00 | | Inventor | COOPER, David, 9 Webb Farm Road
Monroe, New York 10950, US,
JANSEN, Kathrin Ute, 160 E. 65th Street Apt. 11C
New York, New York 10065, US,
PRIDE, Michael William, 80 Bay Street Landing
Unit 8A
Staten Island, New York 10301, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/09 (2006.01) , A61K 39/385 (2006.01) | | Title | Immunogene sammensætninger til anvendelse i pneumokokvacciner | | Int. application no. | IB2016050036 | | Int. publication no. | WO2016113644 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
